# Investigation of Urinary Biomarkers for the Detection of Breast Cancer

> **NCT05453591** · NA · UNKNOWN · sponsor: **Novosanis NV** · enrollment: 200 (estimated)

## Conditions studied

- Breast Cancer
- Urine
- Liquid Biopsy

## Interventions

- **DEVICE:** Colli-Pee UAS devices

## Key facts

- **NCT ID:** NCT05453591
- **Lead sponsor:** Novosanis NV
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-21
- **Primary completion:** 2023-12
- **Final completion:** 2024-04
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05453591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05453591, "Investigation of Urinary Biomarkers for the Detection of Breast Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05453591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*